Previous 10 | Next 10 |
BeiGene (NASDAQ: BGNE) , a Chinese biopharmaceutical company, saw its shares rise 33.7% on Wednesday. The stock closed at $146.52 on Tuesday but opened at $175.82 today and rose as high as $195.95 in the first hour of trading. So far this year, the stock is still down more than 45%....
Gainers: Zai Lab (NASDAQ:ZLAB) +27%. 111 (NASDAQ:YI) +26%. LianBio (NASDAQ:LIAN) +22%. BeiGene BGNE +20%. Palisade Bio PALI +10%. Losers: Talis Biomedical (NASDAQ:TLIS) -42%. Incannex Healthcare (NASDAQ:IXHL) -32%. NLS Pharmaceutics NLSP&...
Chinese stocks have experienced the worst sell-off since the 2008 global financial crisis. The culmination of geopolitical and COVID-19 risks has created a perfect storm for investors. We discuss how investors should position themselves. For further details see: Chinese ...
BeiGene (NASDAQ:BGNE) and its partner Medison Pharma Ltd. announced on Tuesday that Israel approved its tyrosine kinase inhibitor Brukinsa for adults with Waldenström’s Macroglobulinemia (WM), a rare form of B-cell lymphoma. The companies said that Brukinsa would also be reimburse...
Second Regulatory Approval for BRUKINSA in Israel BeiGene (NASDAQ: BGNE; HKEX: 06160, SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, and Medis...
Concord, Mass.-based Adiso Therapeutics, an anti-inflammatory biotech, officially emerged from stealth mode with backing from Hong Kong's Morningside Ventures. Morningside has already invested $60 million in the company and has another $35 million earmarked for the company's B round. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Chinese stock delisting news today has several big names in the country seeing their shares slip on fears they could be next. Source: humphery / Shutterstock.com The U.S. Securities and Exchange Commission (SEC) spe...
Chinese tech stocks were hammered on potential delisting fears. However, we believe that the market reaction was unwarranted. We believe Alibaba and JD.com look attractive now. For further details see: Alibaba And JD.com: Chinese Tech Stocks Hit By Delisting Fears, China...
Hong Kong's Hang Seng Index closed down 1.6% after the U.S. Securities and Exchange Commission named five China-based companies that could be delisted if they don't allow U.S. authorities to review company audits for three straight years. That followed a selloff of U.S.-listed Chinese sh...
BeiGene (NASDAQ:BGNE) said the China National Medical Products Administration (NMPA) granted conditional approval to tislelizumab to treat adult patients with advanced unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors. Th...
News, Short Squeeze, Breakout and More Instantly...
$800 million investment in New Jersey supports global growth and expansion with technologically advanced manufacturing capacity and clinical development capabilities for novel cancer medicines BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today ann...
2024-07-20 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BeiGene , Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Mr. Rosenberg will succeed Julia Wang, who is departing to pursue external opportunities and will stay with the C...